scispace - formally typeset
M

Mark S. Guyer

Researcher at National Institutes of Health

Publications -  54
Citations -  128647

Mark S. Guyer is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Genome & Genomics. The author has an hindex of 46, co-authored 54 publications receiving 116660 citations.

Papers
More filters
Journal ArticleDOI

The NIH Big Data to Knowledge (BD2K) initiative.

TL;DR: The articles that follow from seven of the Centers for Data Excellence that have been funded by the National Institutes of Health (NIH) Big Data to Knowledge (BD2K) initiative provide an overall context for the program.
Journal ArticleDOI

A user's guide to the human genome

TL;DR: The majority of this supplement is devoted to a series of worked examples, providing an overview of the types of data available, details on how these data can be browsed, and stepby-step instructions for using many of the most commonly-used tools for sequence-based discovery.
Journal ArticleDOI

Assessing the Quality of the DNA Sequence from The Human Genome Project

TL;DR: It is sometimes hard to remember that the first DNA sequence of the entire genome of a free-living organism, Hemophilus influenzae, was reported 17 other prokaryotes, and it is important that the Human Genome Project (HGP) devise a way of measuring and reporting the quality of sequence data deposited in the public databases.
Journal ArticleDOI

The Human Genome Project and the Future of Medicine

TL;DR: The rapid progress that has already been made; the impact that the resources already developed have had on the ability of investigators to identify and isolate human genes, particularly those associated with disease; and the promise that the project offers for profoundly altering the approach to medical care.
Journal ArticleDOI

The Ethical, Legal, and Social Implications Program of the National Human Genome Research Institute: Reflections on an Ongoing Experiment*

TL;DR: The program's influence is likely to grow as ELSi research, genomics research, and policy development activities become increasingly integrated, and the benefits of increased integration while preserving the autonomy, objectivity, and intellectual independence of ELSI investigators presents ongoing challenges and new opportunities.